Successful Use of COVID-19 Convalescent Plasma in a Patient Recently Treated for Follicular Lymphoma

Clin Lymphoma Myeloma Leuk. 2021 Jan;21(1):66-68. doi: 10.1016/j.clml.2020.06.012. Epub 2020 Jun 25.

Authors

Zachary Wright¹, Adrian Bersabe², Rina Eden³, Jessica Bradley³, Andrew Cap⁴

Affiliations

¹ Hematology/Oncology, Keesler Medical Center, Keesler Air Force Base, Biloxi, MS. Electronic address: zwright05@gmail.com.
² Hematology/Oncology, Keesler Medical Center, Keesler Air Force Base, Biloxi, MS.
³ Department of Pathology, Keesler Medical Center, Keesler Air Force Base, Biloxi, MS.
⁴ United States Army Institute of Surgical Research, Uniformed Services University, Joint Base San Antonio-Fort Sam Houston, San Antonio, TX.

No abstract available

Keywords: CCP; COVID; Hypogammaglobulinemia; Lymphopenia; lymphoma.

Publication types

Case Reports

MeSH terms

COVID-19 / diagnosis
COVID-19 / therapy*
COVID-19 / virology
COVID-19 Serotherapy
Humans
Immunization, Passive / methods
Lymphoma, Follicular / therapy*
Male
Middle Aged
SARS-CoV-2 / physiology
Treatment Outcome